Oestrogen effects on urine concentrating response in young women

Journal of Physiology

Volumn 552, Issue 3, 2003, Pages 869-880

  Stachenfeld, Nina S ^a   Taylor, Hugh S ^a   Leone, Cheryl A ^a   Keefe, David L ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; ESTROGEN; GONADORELIN DERIVATIVE; LEUPRORELIN; PROGESTERONE; SODIUM ION; WATER;

ADULT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; FEMALE; FLUID BALANCE; FLUID RETENTION; FREE WATER CLEARANCE; HORMONE RELEASE; HORMONE SENSITIVITY; HUMAN; HUMAN EXPERIMENT; KIDNEY CONCENTRATING CAPACITY; NONLINEAR REGRESSION ANALYSIS; NORMAL HUMAN; PLASMA CLEARANCE; PLASMA OSMOLALITY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; REVIEW; SODIUM BALANCE; SODIUM EXCRETION; URINE OSMOLALITY; ARTICLE; BLOOD ANALYSIS; OSMOSIS; RENAL SYSTEM PARAMETERS; SODIUM ABSORPTION; URINALYSIS; URINE CONCENTRATING RESPONSE;

ADMINISTRATION, CUTANEOUS; ADULT; ARGININE VASOPRESSIN; BODY WATER; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; KIDNEY; KIDNEY CONCENTRATING ABILITY; LEUPROLIDE; NATRIURESIS; OSMOLAR CONCENTRATION; URINE;

EID: 0242558885     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2003.046920     Document Type: Review

References (61)

1. Ayus JC & Arieff AI (1996). Brain damage and postoperative hyponatremia: the role of gender. Neurology 46, 323-328.
2. Barron WM, Cohen LH, Ulland LA, Lassiter WE, Fulghum EM, Emmanouel D, Robertson G & Lindheimer MD (1984). Transient vasopressin resistant diabetes insipidus during pregnancy. N Eng J Med 310, 442-444.
3. Berl T, Raz A, Wald H, Horowitz J & Czaczkes W (1977). Prostaglandin synthesis and the action of vasopressin: studies in man and rat. Am J Physiol Renal Physiol 232, F529-537.
4. Brenner BM, Ballerman BJ, Gunning ME & Zeidel ML (1990). Diverse biologicial actions of atrial natriuretic peptide. Physiol Rev 70, 665-699.
5. Brunette M & Leclerc M (2001). Effect of estrogen on calcium and sodium transport by the nephron luminal membranes. J Endocrinol 170, 441-450.
6. Burgess LH & Handa RJ (1992). Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor mediated functions in female rats. Endocrinology 131, 1261-1269.
7. Calzone WL, Silva C, Keefe DL & Stachenfeld NS (2001). Progesterone does not alter osmotic regulation of AVP. Am J Physiol Regul Integr Comp Physiol 281, R2011-2020.
8. Carlberg KA, Fregley MJ & Fahey M (1984). Effects of chronic estrogen treatment on water exchange in rats. Am J Physiol Endocrinol Metab 247, E101-110.
9. Claybaugh JR & Sato AK (1985). Factors influencing urinary vasopressin concentration. Fed Proc 44, 62-65.
10. Claybaugh JR & Uyehara CF (1993). Metabolism of neurohypophysial hormones. Ann N Y Acad Sci 689, 250-268.
11. Colton T (1974). Statistics in Medicine. Little, Brown & Company (Inc.), USA.
12. Crofton JT, Ratliff DL, Brooks DP & Share L (1986). The metabolic clearance rate of and pressor responses to vasopresssin in male and female rats. Endocrinology 118, 1777-1781.
13. De Feo P (1996). Hormonal regulation of human protein metabolism. Eur J Endocrinol 135, 7-18.
14. Dixey JJ, Williams TDM, Lightman SL, Lant AF & Brewerton DA (1986). The effect of indomethacin on the renal response to arginine vasopressin in man. Clin Sci (Lond) 70, 409-416.
15. + pump activity in cultured guinea-pig tracheal smooth muscle cells. Br J Pharmacol 133, 1339-1345.
16. Dubey R & Jackson E (2001). Estrogen-induced cardiorenal protection: potential cellular, biochemical and molecular mechanisms. Am J Physiol Renal Physiol 280, F365-388.
17. Farker K, Schweer H, Vollandt R, Nassr N, Nagel U, Seyberth HW, Hoffman NA & Oettel M (1997). Measurements of urinary prostaglandins in young ovulatory women during the menstrual cycle and in postmenopausal women. Prostaglandins 54, 655-664.
18. Farman N, Oblin ME, Lombes M, Delahaye F, Westphal HM, Bonvalet JP & Gasc JM (1991). Immunolocalization of gluco- and mineralocorticiod receptors in the rabbit kidney. Am J Physiol Cell Physiol 260, C226-233.
19. Forsling ML, Akerlund M & Stromberg P (1981). Variations in plasma concentrations of vasopressin during the menstrual cycle. J Endocrinol 89, 263-266.
20. Fortney SM, Beckett WS, Carpenter AJ, Davis J, Drew H, Lafrance ND, Rock JA, Tankersley CG & Vroman NB (1988). Changes in plasma volume during bed rest: effects of menstrual cycle and estrogen administration. J Appl Physiol 65, 525-533.
21. Fortney SM, Turner C, Steinmann L, Driscoll T & Alfrey C (1994). Blood volume responses of men and women to bed rest. J Clin Pharmacol 34, 434-439.
22. Freund BJ, Claybaugh JR, Dice MS & Hashiro GM (1987). Hormonal and vascular fluid responses to maximal exercise in trained and untrained males. J Appl Physiol 63, 669-675.
23. Freund BJ, Shizuru EM, Hashiro GM & Claybaugh JR (1991). Hormonal, electrolyte, and renal responses to exercise are intensity dependent. J Appl Physiol 70, 900-906.
24. Gaebelein CJ & Senay LC (1982). Vascular volume dynamics during ergometer exercise at different menstrual phases. Eur J Appl Physiol 50, 1-11.
25. Greenleaf JE, Convertino VA & Mangseth GR (1979). Plasma volume during stress in man: osmolality and red cell volume. J Appl Physiol 47, 1031-1038.
26. Hatano T, Ogawa K, Kanda K, Seo H & Masui N (1988). Effect of ovarian steroids on cyclicadenosine 3′:5′ monophosphate production stimulated by arginine vasopressin in rat renal monolayer cells. Endocrinol Jpn 35, 267-274.
27. Hollenberg NK, Williams GH, Burger B, Chenitz W, Hoosmand J & Adams DF (1976). Renal blood flow and its response to angiotensin II. An interaction between oral contraceptive agents, sodium intake, and the renin-angiotensin system in healthy young women. Circ Res 38, 35-40.
28. 2 antagonist on clearance of arginine vasopressin by isolated perfused rat kidneys. Am J Physiol Regul Integr Comp Physiol 261, R665-669.
29. Kuroski de Bold ML (1999). Estrogen, natriuretic peptides and the renin-angiontensin system. Cardiovasc Res 41, 524-531.
30. Mahajan DK, Billiar RB, Jassani M & Little AB (1978). Ethinyl estradiol administration and plasma steroid concentrations in ovariectomized women. Am J Obstet Gynecol 130, 398-402.
31. Merkelbach U, Czernichow P, Gaillard RC & Vallotton MB (1975). Radioimmunoassay of [8-argininel vasopressin. II. Application to determination of antidiuretic hormone in urine. Acta Endocrinol 80, 453-464.
32. Moses AM & Steciak E (1986). Urinary and metabolic clearances of arginine vasopressin in normal subjects. Am J Physiol Regul Integr Comp Physiol 251, R365-370.
33. Mosselman S, Polman J & Dijkema R (1996). ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 392, 49-53.
34. 2α and E during induction of ovulation with human gonadotropins. Prostaglandins Leukot Med 13, 197-209.
35. Mulay S, D'Sylva S & Varma DR (1993). Inhibition of the aldosterone-suppressant activity of atrial natriuretic factor by progesterone and pregnancy in rats. Life Sci 52, 1121-1128.
36. Myles K & Funder JW (1996). Progesterone binding to mineralocorticoid receptors: in vitro and vivo studies. Am J Physiol Endocrinol Metab 270, E601-607.
37. Neugarten J, Acharya A & Silbiger S (2000). Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 11, 319-329.
38. 131I]iodovasopressin in the hypophysectomized dog. Endocrinology 99, 1199-1206.
39. Share L, Kimura T, Matsui K, Shade RE & Crofton JT (1985). Metabolism of vasopressin. Fed Proc 44, 59-61.
40. Siggaard-Andersen O, Wimberley PD, Gothgen I & Siggaard-Andersen M (1984). A mathematical model of the hemoglobin-oxygen dissociate curve of human blood and of the oxygen partial pressure as a function of temperature. Clin Chem 30, 1646-1651.
41. Silbiger SR & Neugarten J (1995). The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25, 515-533.
42. Sills ES, Lescale KB & Strider WE (1995). Transient vasopressin-sensitive diabetes insipidus associated with pregnancy: case report and review of the literature. J Matern Fetal Med 4, 81-84.
43. Spruce BA, Baylis PH, Burd J & Watson MJ (1985). Variation in osmoregulation of arginine vasopressin during the human menstrual cycle. Clin Endocrinol 22, 37-42.
44. Stachenfeld NS, DiPietro L, Palter SF & Nadel ER (1998a). Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women. Am J Physiol Regul Integr Comp Physiol 274, R187-195.
45. Stachenfeld NS & Keefe DL (2002). Estrogen effects on osmotic regulation of AVP and fluid balance. Am J Physiol Endocrinol Metab 283, E711-721.
46. Stachenfeld NS, Keefe DL & Palter SF (2001a). Effects of estrogen and progesterone on transcapillary fluid dynamics. Am J Physiol Regul Integr Comp Physiol 281, R1319-1329.
47. Stachenfeld NS, Mack GW, DiPietro L, Morocco TS, Jozsi AC & Nadel ER (1998b). Regulation of blood volume during training in post-menopausal women. Med Sci Sports Exers 30, 92-98.
48. Stachenfeld NS, Silva CS, Keefe DL, Kokoszka CA & Nadel ER (1999). Effects of oral contraceptives on body fluid regulation. J Appl Physiol 87, 1016-1025.
49. Stachenfeld NS, Splenser AE, Calzone WL, Taylor MP & Keefe DL (2001b). Sex differences in osmotic regulation of AVP and renal sodium handling. J Appl Physiol 91, 1893-1901.
50. 2 and thromboxane B, in normal menstruating women. Am J Reprod Immunol 10, 47-52.
51. 3 in rat kidney: comparison with localization of parathyriod hormone and estradiol. Proc Natl Acad Sci U S A 77, 1149-1153.
52. Thomsen K (1984). Lithium clearance: A new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 37, 217-223.
53. Thomsen K (1990). Lithium clearance as a measure of sodium and water delivery from the proximal tubules. Kidney Int 28, S10-16.
54. Trigoso WF, Wesly JM, Meranda DL & Shenker Y (1996). Vasopressin and atrial natriuretic peptide hormone responses to hypertonic saline infusion during the follicular and luteal phases of the menstrual cycle. Hum Reprod 11, 2392-2395.
55. Vago T, Bevilacquia M, Conci F, Rogolino A & Norbiato G (1995). Pharmacologic data reveal the heterogeneity of antiotensin-converting enzyme according to its source (lung versus heart). Am J Cardiol 75, 13-17F.
56. Vallotton MB, Merkelbach BV & Gaillard RC (1983). Studies of the factors modulating antidiuretic hormone excretion in man in response to the osmolar stimulus: effects of oestrogen and angiotensin II. Acta Endocrinol 104, 295-302.
57. Veriander JW, Tran TM, Zhang L, Kaplan MR & Hebert SC (1998). Estradiol enhances thiazide-sensitive NaCl cotransporter density in the apical plasma membrane of the distal convoluted tubule in ovariectomized rats. J Clin Invest 101, 1661-1669.
58. Wang Y-X, Crofton JT, Liu H-W, Brooks DP & Share L (1994). Effect of gonadectomy on sexually dimorphic antidiuretic action of vasopressin in conscious rats. Am J Physiol Regul Integr Comp Physiol 267, R536-541.
59. Wang Y-X, Crofton JT, Liu H, Sato K, Brooks DP & Share L (1995). Estradiol attenuates the antidiuretic action of vasopressin in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 268, R951-957.
60. Wang Y-X, Edwards RM, Nambi P, Stack EJ, Pullen M, Share L, Crofton JT & Brooks DP (1993). Sex difference in the antidiuretic acitivity of vasopressin in the rat. Am J Physiol Regul Integr Comp Physiol 265, R1284-1290.
61. Weitzman RE & Fisher DA (1978). Arginine vasopressin metabolism in dogs. I. Evidence for a receptor mediated mechanism. Am J Physiol Endocrinol Metab 235, E591-597.